The LSD1 Inhibitor Iadademstat Is Active in Acute Myeloid Leukemia.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2020-155
Abstract: In a phase I trial, iadademstat induced blast differentiation and reduced bone marrow blast burden. read more here.
Keywords: inhibitor iadademstat; acute myeloid; myeloid leukemia; lsd1 inhibitor ... See more keywords